Apolipoprotein E4 Potentiates Amyloid β Peptide-induced Lysosomal Leakage and Apoptosis in Neuronal Cells*
暂无分享,去创建一个
R. Mahley | K. Weisgraber | Yadong Huang | Yadong Huang | R. D. Miranda | R Dennis Miranda | Robert W Mahley | Karl H Weisgraber | Y. Newhouse | Z. Ji | Zhong-Sheng Ji | Yvonne M Newhouse
[1] Y. Lazebnik,et al. Caspases: enemies within. , 1998, Science.
[2] Jan Xu,et al. Amyloid β Peptide–Induced Cerebral Endothelial Cell Death Involves Mitochondrial Dysfunction and Caspase Activation , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[3] S. Paul,et al. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[4] J. Vandekerckhove,et al. ApoE protects cortical neurones against neurotoxicity induced by the non‐fibrillar C‐terminal domain of the amyloid‐β peptide , 2001, Journal of Neurochemistry.
[5] A. Yang,et al. Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Aβ1‐42 pathogenesis , 1998, Journal of neuroscience research.
[6] S. Lavrentiadou,et al. Contribution of cysteine 158, the glycosylation site threonine 194, the amino- and carboxy-terminal domains of apolipoprotein E in the binding to amyloid peptide beta (1-40). , 1999, Biochemistry.
[7] R. Mahley,et al. Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells. , 1993, The Journal of biological chemistry.
[8] R. Nixon,et al. Properties of the endosomal-lysosomal system in the human central nervous system: disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[9] K. Weisgraber,et al. Conformational Reorganization of the Four-helix Bundle of Human Apolipoprotein E in Binding to Phospholipid* , 2000, The Journal of Biological Chemistry.
[10] Y. Christen,et al. Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype. , 1999, Free radical biology & medicine.
[11] J. Weinstein,et al. The interaction of apolipoprotein A-I with small unilamellar vesicles of L-alpha-dipalmitoylphosphatidylcholine. , 1985, The Journal of biological chemistry.
[12] M. Greenberg,et al. β-Amyloid Induces Neuronal Apoptosis Via a Mechanism that Involves the c-Jun N-Terminal Kinase Pathway and the Induction of Fas Ligand , 2001, The Journal of Neuroscience.
[13] R. Brasseur,et al. Specific modulation of the fusogenic properties of the Alzheimer beta-amyloid peptide by apolipoprotein E isoforms. , 1997, European journal of biochemistry.
[14] K. Weisgraber. Apolipoprotein E: structure-function relationships. , 1994, Advances in protein chemistry.
[15] B. Rupp,et al. Differences in stability among the human apolipoprotein E isoforms determined by the amino-terminal domain. , 2000, Biochemistry.
[16] R. Mahley,et al. Apolipoprotein E: far more than a lipid transport protein. , 2000, Annual review of genomics and human genetics.
[17] D. Holtzman,et al. α2‐Macroglobulin Complexes with and Mediates the Endocytosis of β‐Amyloid Peptide via Cell Surface Low‐Density Lipoprotein Receptor‐Related Protein , 1997 .
[18] R. Mahley,et al. Clearance of chylomicron remnants by the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. , 1991, The Journal of biological chemistry.
[19] B. Hyman,et al. α2‐Macroglobulin Enhances the Clearance of Endogenous Soluble β‐Amyloid Peptide via Low‐Density Lipoprotein Receptor‐Related Protein in Cortical Neuron , 1999 .
[20] D. Selkoe,et al. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids , 1992, Nature.
[21] K. Yoshikawa,et al. Activation of Neuronal Caspase-3 by Intracellular Accumulation of Wild-Type Alzheimer Amyloid Precursor Protein , 1999, Journal of Neuroscience.
[22] C. Cotman,et al. Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[23] L. Mucke,et al. Dominant negative effects of apolipoprotein E4 revealed in transgenic models of neurodegenerative disease , 2000, Neuroscience.
[24] F. LaFerla,et al. Extracellular deposition of beta-amyloid upon p53-dependent neuronal cell death in transgenic mice. , 1996, The Journal of clinical investigation.
[25] D. Kirschner,et al. On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[26] A. Fagan,et al. Apolipoprotein E-containing High Density Lipoprotein Promotes Neurite Outgrowth and Is a Ligand for the Low Density Lipoprotein Receptor-related Protein* , 1996, The Journal of Biological Chemistry.
[27] H. Brewer,et al. Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments , 1994, Nature.
[28] F. Young. Biochemistry , 1955, The Indian Medical Gazette.
[29] G. Siest,et al. Differential oxidation of apolipoprotein E isoforms and interaction with phospholipids. , 2000, Free radical biology & medicine.
[30] D. Wilkin,et al. Neuron , 2001, Brain Research.
[31] D. Butterfield. beta-Amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease. , 1997, Chemical research in toxicology.
[32] Marcel Leist,et al. Cathepsin B Acts as a Dominant Execution Protease in Tumor Cell Apoptosis Induced by Tumor Necrosis Factor , 2001, The Journal of cell biology.
[33] D. Selkoe,et al. Alzheimer's Disease: A Central Role for Amyloid , 1994, Journal of neuropathology and experimental neurology.
[34] M. Pericak-Vance,et al. Apolipoprotein E ∈4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases , 1993, The Lancet.
[35] C. Dobson. The structural basis of protein folding and its links with human disease. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[36] Z. Janka,et al. Apolipoprotein E polymorphism in Pick’s disease and in Huntington’s disease , 2000, Neurobiology of Aging.
[37] L. Ellerby,et al. Lysosomal Protease Pathways to Apoptosis , 2001, The Journal of Biological Chemistry.
[38] Manjit,et al. Neurology , 1912, NeuroImage.
[39] C. Glabe,et al. Preferential adsorption, internalization and resistance to degradation of the major isoform of the Alzheimer's amyloid peptide, Aβ1–42, in differentiated PC12 cells , 1997, Brain Research.
[40] O. Ptitsyn,et al. Molten globule and protein folding. , 1995, Advances in protein chemistry.
[41] L. Mucke,et al. Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[42] L. Greene,et al. β‐Amyloid‐induced neuronal apoptosis requires c‐Jun N‐terminal kinase activation , 2001, Journal of neurochemistry.
[43] K. Roberg,et al. Lysosomal release of cathepsin D precedes relocation of cytochrome c and loss of mitochondrial transmembrane potential during apoptosis induced by oxidative stress. , 1999, Free radical biology & medicine.
[44] D. Butterfield,et al. Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. , 2000, Journal of structural biology.
[45] D. Holtzman,et al. Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[46] M. Brown,et al. Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. , 1983, Methods in enzymology.
[47] J. Weinstein,et al. Phase transition release, a new approach to the interaction of proteins with lipid vesicles. Application to lipoproteins. , 1981, Biochimica et biophysica acta.
[48] A. D. Roses,et al. Association of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer’s disease , 2006 .
[49] Junying Yuan,et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β , 2000, Nature.
[50] T. Willnow,et al. Functions of the LDL Receptor Gene Family , 1994, Annals of the New York Academy of Sciences.
[51] T Vogel,et al. Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. , 1994, The American journal of pathology.
[52] S. Younkin,et al. Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice , 1996, Science.
[53] Xudong Huang,et al. The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. , 1999, Biochemistry.
[54] P. Matsudaira,et al. Generation of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[55] D. Strickland,et al. LRP in Alzheimer's disease: friend or foe? , 2000, The Journal of clinical investigation.
[56] G. Getz,et al. Association of human, rat, and rabbit apolipoprotein E with β‐amyloid , 1997, Journal of neuroscience research.
[57] O. Khorkova,et al. α2-macroglobulin associates with β-amyloid peptide and prevents fibril formation , 1998 .
[58] J. Haines,et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.
[59] T. Pillot,et al. The nonfibrillar amyloid beta-peptide induces apoptotic neuronal cell death: involvement of its C-terminal fusogenic domain. , 2002, Journal of neurochemistry.
[60] R. Katzman.,et al. Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway. , 2000, The Journal of clinical investigation.
[61] L. S. Perlmutter,et al. β-Amyloid induces apoptosis in human-derived neurotypic SH-SY5Y cells , 1996, Brain Research.
[62] R. Wetzel,et al. Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide. , 1995, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.
[63] G. Glenner,et al. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein , 1984 .
[64] M. Mattson,et al. A Mechanism for the Neuroprotective Effect of Apolipoprotein E , 2000, Journal of neurochemistry.
[65] M. Pericak-Vance,et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[66] C. Masters,et al. Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[67] D. Perlmutter,et al. The Serpin-Enzyme Complex Receptor Recognizes Soluble, Nontoxic Amyloid-β Peptide but Not Aggregated, Cytotoxic Amyloid-β Peptide* , 1996, The Journal of Biological Chemistry.
[68] A. Fagan,et al. No effect of apolipoprotein E on neuronal cell death due to excitotoxic and apoptotic agents in vitro and neonatal hypoxic ischaemia in vivo , 2000, The European journal of neuroscience.
[69] C. Bergeron,et al. Caspase-6 Role in Apoptosis of Human Neurons, Amyloidogenesis, and Alzheimer’s Disease* , 1999, The Journal of Biological Chemistry.
[70] S. Rabacchi,et al. Caspase-2 Mediates Neuronal Cell Death Induced by β-Amyloid , 2000, The Journal of Neuroscience.
[71] A. von Eckardstein,et al. Overexpression and Accumulation of Apolipoprotein E as a Cause of Hypertriglyceridemia* , 1998, The Journal of Biological Chemistry.
[72] B. Yankner. Mechanisms of Neuronal Degeneration in Alzheimer's Disease , 1996, Neuron.
[73] D. Graham,et al. Amyloid β‐Protein, APOE Genotype and Head Injury , 1996 .
[74] Rui F. M. Silva,et al. Bilirubin and Amyloid-β Peptide Induce Cytochrome c Release Through Mitochondrial Membrane Permeabilization , 2000, Molecular medicine.
[75] M. Pericak-Vance,et al. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[76] F. Maxfield,et al. Microglial Cells Internalize Aggregates of the Alzheimer's Disease Amyloid β-Protein Via a Scavenger Receptor , 1996, Neuron.
[77] S. Estus,et al. Aggregated Amyloid-β Protein Induces Cortical Neuronal Apoptosis and Concomitant “Apoptotic” Pattern of Gene Induction , 1997, The Journal of Neuroscience.
[78] M. Berridge,et al. Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. , 1993, Archives of biochemistry and biophysics.
[79] K. Roth. Caspases, Apoptosis, and Alzheimer Disease: Causation, Correlation, and Confusion , 2001, Journal of neuropathology and experimental neurology.
[80] R. Mahley,et al. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. , 1994, Science.
[81] R J Miller,et al. Isoform-Specific Effect of Apolipoprotein E on Cell Survival and β-Amyloid-Induced Toxicity in Rat Hippocampal Pyramidal Neuronal Cultures , 1998, The Journal of Neuroscience.
[82] R. Mahley,et al. Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[83] R. Krüger,et al. Increased susceptibility to sporadic Parkinson's disease by a certain combined α‐synuclein/apolipoprotein E genotype , 1999, Annals of neurology.
[84] K. Roberg. Relocalization of Cathepsin D and Cytochrome c Early in Apoptosis Revealed by Immunoelectron Microscopy , 2001, Laboratory Investigation.
[85] J. Swanson,et al. Tubular lysosomes accompany stimulated pinocytosis in macrophages , 1987, The Journal of cell biology.
[86] R. Brasseur,et al. β‐Amyloid Peptide Interacts Specifically with the Carboxyl‐Terminal Domain of Human Apolipoprotein E , 1999, Journal of Neurochemistry.
[87] A. Fagan,et al. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[88] L. Ellerby,et al. Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[89] R. Dodel,et al. α2‐Macroglobulin as a β‐Amyloid Peptide‐Binding Plasma Protein , 1997 .
[90] Carl W. Cotman,et al. Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[91] M. Gurney,et al. Human apolipoprotein E4 accelerates β‐amyloid deposition in APPsw transgenic mouse brain , 2001, Annals of neurology.
[92] Junying Yuan,et al. Apoptosis in the nervous system , 2000, Nature.
[93] L. Villa-komaroff,et al. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. , 1989, Science.
[94] C. Behl,et al. Hydrogen peroxide mediates amyloid β protein toxicity , 1994, Cell.
[95] T. Morgan,et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[96] Y. Fukui,et al. Amyloid β protein-induced neuronal cell death: neurotoxic properties of aggregated amyloid β protein , 1994, Brain Research.
[97] Steven M. Horvath,et al. Alpha-2 macroglobulin is genetically associated with Alzheimer disease , 1998, Nature Genetics.
[98] Mingde Zhao,et al. Sphingosine-induced apoptosis is dependent on lysosomal proteases. , 2001, The Biochemical journal.
[99] P. Fraser,et al. Review: Modulating Factors in Amyloid-β Fibril Formation , 2000 .
[100] L. Mucke,et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein , 1995, Nature.
[101] E Brisch,et al. The Inhibitory Effect of Apolipoprotein E4 on Neurite Outgrowth Is Associated with Microtubule Depolymerization (*) , 1995, The Journal of Biological Chemistry.
[102] T. Wisniewski,et al. Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E. , 1995, The Biochemical journal.
[103] Q. Fan,et al. A Novel Action of Alzheimer's Amyloid β-Protein (Aβ): Oligomeric Aβ Promotes Lipid Release , 2001, The Journal of Neuroscience.
[104] D. Holtzman,et al. Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. , 2000, The Journal of clinical investigation.
[105] A. Roses,et al. Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. , 1994, The Journal of clinical investigation.
[106] R. Mahley,et al. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.
[107] R. Mahley,et al. Stable Expression and Secretion of Apolipoproteins E3 and E4 in Mouse Neuroblastoma Cells Produces Differential Effects on Neurite Outgrowth (*) , 1995, The Journal of Biological Chemistry.
[108] R. Martins,et al. Apolipoprotein E promotes the binding and uptake of β-amyloid into Chinese hamster ovary cells in an isoform-specific manner , 1999, Neuroscience.
[109] D. Agard,et al. Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. , 1994 .
[110] Y. Uchiyama,et al. Regulation of a novel pathway for cell death by lysosomal aspartic and cysteine proteinases , 1999, Neuroscience.
[111] Jonathan D. Smith,et al. Apolipoprotein E allele–specific antioxidant activity and effects on cytotoxicity by oxidative insults and β–amyloid peptides , 1996, Nature Genetics.